Acarbose
Acarbose is a prescription alpha-glucosidase inhibitor used to manage type 2 diabetes by delaying carbohydrate digestion and reducing post-meal blood glucose.
Acarbose, derived from Actinoplanes bacteria, is an oral pharmaceutical used alongside diet and other therapies to improve glycemic control in people with type 2 diabetes. It slows carbohydrate absorption in the intestine, blunting postprandial rises in blood sugar.
Supported by multiple clinical trials, meta-analyses, and real-world data for glycemic and secondary cardiovascular benefits.
Improves postprandial blood glucose control
StrongAcarbose consistently reduces post-meal glucose spikes and lowers HbA1c by 0.5–1% in type 2 diabetes patients.
May decrease cardiovascular event risk
ModerateLong-term use of acarbose in prediabetic and diabetic individuals may reduce risk of cardiovascular events, likely via improved glycemic control and anti-inflammatory effects.
Modest support for weight management
ModerateAcarbose is associated with minor weight loss or prevention of weight gain in type 2 diabetes, likely due to reduced caloric absorption and increased satiety.
Laatst bijgewerkt: